Skip to main content

Volume 12 Supplement 1

Breast Cancer Research 2010

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy


Insulin-like growth factor binding protein-2 (IGFBP-2) is often elevated in breast tumours and the presence of IGFBP-2 has been shown to correlate with malignancy. Previously we have shown that IGFBP-2 reduces PTEN abundance [1] and thus helps to maintain the activity of the phosphoinositide 3-kinase signalling cascade, a key mitogenic and survival pathway.


We therefore investigated whether IGFBP-2 could act as a survival factor for breast cancer cell lines. Using MCF7 and T47D cells, we tested the ability of exogenous IGFBP-2 to alter apoptosis induced by various chemotherapeutic agents. As both these cell lines produce large amounts of IGFBP-2, we also examined the effect of silencing IGFBP-2 using siRNA.


In MCF7 cells, paclitaxel (50 μM) increased cell death from 9% to 24.5% (P < 0.001). Addition of IGFBP-2 (25 ng/ml) decreased the induced cell death by almost one-half to 17.7% (P = 0.047). 5-Fluorouricil (20 μM) increased cell death of T47D cells by 54% (P = 0.044), which was completely blocked by the addition of IGFBP-2. Conversely, loss of IGFBP-2 enhanced chemotherapy-induced apoptosis in both cell lines compared with a nonsilencing siRNA. We also observed that loss of IGFBP-2 reduced cellular proliferation - the live cell number decreased 73% (P < 0.001) and 33% (P < 0.001) in the MCF7 and T47D cells, respectively. Additionally, in the MCF7 cells, loss of IGFBP-2 alone increased cell death threefold (P < 0.001).


These data show that the production of IGFBP-2 by breast cancer cells enhances their survival and protects them against chemotherapy. Thus in breast tumours the increase in IGFBP-2 production could be a survival mechanism making IGFBP-2 a legitimate target for intervention.


  1. Perks CM, Vernon EG, Rosenthal AH, Tonge D, Holly JM: IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene. 2007, 26: 5966-5972. 10.1038/sj.onc.1210397.

    Article  CAS  PubMed  Google Scholar 

Download references


This research was funded by Breast Cancer Campaign.

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Foulstone, E., Holly, J., Zeng, L. et al. Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy. Breast Cancer Res 12 (Suppl 1), P22 (2010).

Download citation

  • Published:

  • DOI: